jRCT2051260093已完成不适用
Double-blind comparative trial of TP-1222
未提供0 个研究点目标入组 360 人开始时间: 待定
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 360
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
入排标准
- 年龄范围
- 20age old over 至 No limit（—）
- 性别
- Female
入选标准
- •(1) Age at the time of obtaining informed consent: 20 years or
- •(2) Subjects diagnosed with androgenetic alopecia classified as
- •Ludwig Class I or II.
- •(3) Subjects with disease onset within a specified period
- •(4) Subjects meeting predefined hair criteria required for efficacy
排除标准
- •(1) Subjects with serious comorbidities, or with a history of
- •serious hepatic, renal, cardiac, or hematologic disease.
- •(2) Subjects receiving treatment for hypotension or
- •hypertension.
- •(3) Subjects with concomitant skin diseases at the application
- •site other than androgenetic alopecia.
- •(4) Subjects who have participated in another clinical trial and
- •received an investigational product within 16 weeks prior to the
- •start of investigational product administration in this study.
- •(5) Subjects with alopecia other than androgenetic alopecia.
- •(6) Subjects who have received treatments that may affect hair
- •growth (e.g., minoxidil, hormonal treatments, hair regeneration
- •(7) Pregnant or breastfeeding women
研究者
相似试验
招募中
不适用
A clinical study of TS-172 in hyperphosphatemia patients on peritoneal dialysisHyperphosphatemiajRCT203126005330
招募中
不适用
A clinical study of TS-172 in hyperphosphatemia patients on hemodialysisHyperphosphatemiajRCT203126005430
招募中
2 期
A Phase 2b Clinical Study to Evaluate the Safety and Efficacy of Topical Administration of
Bacteriophage Therapy TP-102 in Patients with Diabetic Foot Infection2023-507716-13-00Technophage Investigacao E Desenvolvimento Em Biotecnologia S.A.26
招募中
3 期
A Study To Comapre the Effects of Two Ayurvedic Medicine, Srikhandasava And Patolakaturohinyadi Kashaya, In adults with Alcoholic Fatty Liver Grade II for improving Liver health and Reducing Liver Fat.CTRI/2025/11/097833Dr Sunil Kumar200
已完成
3 期
A prospective, randomized, double-blind placebo-controlled multicentre study with mannan-conjugated birch pollen allergoids administered subcutaneously to adolescent and adult patients with birch pollen-induced allergic rhinitis or rhinoconjunctivitis.2023-508013-16-00CCDRD Cooperative Clinical Drug Research and Development AG, Inmunotek S.L., ClinCompetence Cologne GmbH600